Unitaid press release
In December 2025, Unitaid approved an additional US$31 million to support two new projects designed with countries to expand access to lenacapavir, a twice-yearly injectable for HIV prevention. This new investment builds on Unitaid’s earlier US$22 million commitment announced in November 2024 to accelerate access to this innovative prevention option. Together, these projects complement efforts in South Africa and Zambia to roll out lenacapavir over the next three years and reinforce Unitaid’s broader work to ensure that new HIV prevention tools reach people who need them as quickly and equitably as possible.
Read the full press release here.
Source : Unitaid
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.